Categories
Tags
Abbott Advertising AstraZeneca Barack Obama Big Pharma Biotechnology and Pharmaceuticals Bristol Myers Squibb business Cancer Clinical trial conference Deal Eli Lilly European Commission European Union Facebook FDA Food and Drug Administration Genentech generics GlaxoSmithKline Google GSK HBA Health Health care Johnson & Johnson layoffs Lilly Marketing Merck Novartis Pfizer Pharma Pharmaceutical drug pharmaceutical industry Research and development Roche Sanofi-Aventis Schering Plough social media Twitter U.S. Food and Drug Administration United States Wyeth
Technology News
BioPharm News
Clinical Trials NewsBlogroll
-
Meta
Tag Archives: GlaxoSmithKline
One to Watch: Q&A with Paul Dyer
Paul Dyer, eMedia Director, WeissComm Group (WCG), is already on his way to the top not only on PR News’ 15 to watch list, but also as an emerging leader in the online healthcare landscape.
At 26, Paul Dyer has a long list of accolades that most young professionals his age only dream about. As eMedia [...]
Posted in Marketing, People Also tagged Advertising and Marketing, Health care, Marketing, Mass media, Pfizer, Virgin Megastore, Walgreens Leave a comment
The Trouble with Transparency
Guest blog by Jacky Law
A couple of weeks ago I attended an industry awards dinner and had an interesting conversation with an eminent doctor who shall remain nameless. The doctor in question works in a highly specialized area and frequently talks about her research at conferences around the world. She always travels first-class and has [...]
Posted in Guest Blog, Strategy Also tagged Congress, Eli Lilly, Herb Kohl, Medicine, Member of Parliament, United States Senate Committee on Finance, US Leave a comment
Pharma Celebrates its Own
At the gala ceremony for the 2009 Prix Galien USA award on October 1, a paradigm shift in drug development took center stage.
“The most successful new [cancer] therapies will be based on a precise molecular understanding of disease basis—that’s exactly what we did with Gleevec,” said keynote speaker Brian Druker, director of the Oregon Health [...]
Prix Galien Push for Private/Public Collaboration
Preceding the presentation of the 2009 Prix Galien USA prizes, last Tuesday, a round table discussion was conducted at the American Museum of Natural History on the subject of how public and private collaboration can increase innovation and contribute to saving lives around the world. The talk included Leonard Bell of Alexion Pharmaceuticals, Barry Bloom [...]
Posted in Events Also tagged Africa, American Museum of Natural History, Harvard School of Public Health, Jeffrey Sachs, Novartis, Prix Galien, Public health, United States Leave a comment

AstraZeneca to Slash 8,000 More Jobs (Updated 2/3/10)